Vigilant Biosciences

OverviewSuggest Edit

Vigilant Biosciences is a company developing solutions that aid in the early detection and intervention of oral and oropharyngeal cancer. Its product line is based on technology that measures total protein levels and assesses the level of tumor-initiating and stem cell-associated biomarkers in the body.
TypePrivate
Founded2011
Websitevigilantbiosciences.com

Latest Updates

Employees (est.) (Mar 2020)14

Key People/Management at Vigilant Biosciences

Matthew H.J. Kim

Matthew H.J. Kim

Founder & CEO
Robert Hamilton

Robert Hamilton

CFO
John Comisi

John Comisi

Chief Dental Officer
Sally Bowden

Sally Bowden

VP, Regulatory Affairs & Quality Assurance
Robert Bohannon

Robert Bohannon

Head, Product Development
Elizabeth J. Franzmann

Elizabeth J. Franzmann

Scientific Founder & Chief Scientific Officer
Show more

Vigilant Biosciences Financials and Metrics

Summary Metrics

Founding Date

2011

Vigilant Biosciences total Funding

$7 m

Vigilant Biosciences latest funding size

$5 m

Time since last funding

4 years ago
Vigilant Biosciences's latest funding round in July 2016 was reported to be $5 m. In total, Vigilant Biosciences has raised $7 m
Show all financial metrics

Vigilant Biosciences Online and Social Media Presence

Embed Graph

Vigilant Biosciences Frequently Asked Questions

  • When was Vigilant Biosciences founded?

    Vigilant Biosciences was founded in 2011.

  • Who are Vigilant Biosciences key executives?

    Vigilant Biosciences's key executives are Matthew H.J. Kim, Robert Hamilton and John Comisi.

  • How many employees does Vigilant Biosciences have?

    Vigilant Biosciences has 14 employees.

  • Who are Vigilant Biosciences competitors?

    Competitors of Vigilant Biosciences include Embolx, Biosapien and Lindis Bloodcare.